Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Brain Metastases From NSCLC”

68 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 68 results

Not applicableUnknownNCT04787185
What this trial is testing

Stereotactic Radiotherapy in Association With Immunotherapy for the Treatment of NSCLC Brain Metastases

Who this might be right for
Brain Metastases From NSCLC
Azienda Ospedaliero-Universitaria Careggi 50
Large-scale testing (Phase 3)UnknownNCT02714010
What this trial is testing

EGFR-TKI Concurrent With/Without WBRT in Brain Metastasis From NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 601
Testing effectiveness (Phase 2)Ended earlyNCT00234442
What this trial is testing

Iressa in the Treatment of Brain Metastases From Non Small Cell Lung Cancer

Who this might be right for
Brain NeoplasmsNon Small Cell Lung Cancer
AstraZeneca 47
Testing effectiveness (Phase 2)UnknownNCT04213170
What this trial is testing

Sintilimab Combined With Bevacizumab for Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon Small Cell Lung CancerSintilimab+1 more
Sun Yat-sen University 60
Testing effectiveness (Phase 2)WithdrawnNCT04650490
What this trial is testing

SRS Timing With Immune Checkpoint Inhibition in Patients With Untreated Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon Small Cell Lung Cancer
Duke University
Testing effectiveness (Phase 2)UnknownNCT01688713
What this trial is testing

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Brain MetastasesNon-small Cell Lung Cancer
Zhejiang Cancer Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT00872482
What this trial is testing

Nimotuzumab in Combination With Radiation Therapy in Patients With Brain Metastases

Who this might be right for
Metastatic Non-Small Cell Lung Cancer
YM BioSciences 21
Testing effectiveness (Phase 2)Looking for participantsNCT07130786
What this trial is testing

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Who this might be right for
SeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more
Ayal A. Aizer, MD 150
Large-scale testing (Phase 3)UnknownNCT02972333
What this trial is testing

Open Label, Prospective Study to Investigate Efficacy and Safety of AZD9291 in BM From NSCLC Patients With EGFR T790M

Who this might be right for
EGFR-TKI Resistant MutationNonsmall Cell Lung CancerAZD9291+1 more
Shandong Cancer Hospital and Institute 150
Testing effectiveness (Phase 2)UnknownNCT03366376
What this trial is testing

Hippocampus-sparing WBRT and Simultaneous Integrated Boost for Multiple Brain Metastases From NSCLC

Who this might be right for
Brain Metastases
Samsung Medical Center 80
Testing effectiveness (Phase 2)Active Not RecruitingNCT05865990
What this trial is testing

HER3-DXd in Breast Cancer and NSCLC Brain Metastases and Solid Tumor Leptomeningeal Disease

Who this might be right for
Metastatic Breast CancerAdvanced Non-Small Cell Squamous Lung CancerSolid Tumor, Adult
MedSIR 63
Early research (Phase 1)Study completedNCT00536861
What this trial is testing

Safety Study of Radiotherapy and Concurrent Erlotinib (Tarceva®) for Brain Metastases From a Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerBrain Metastases
Amsterdam UMC, location VUmc 11
Early research (Phase 1)Looking for participantsNCT06253871
What this trial is testing

A Phase 1/1b Study of IAM1363 in HER2 Cancers

Who this might be right for
HER2 Mutation-Related TumorsHER2HER2-positive Breast Cancer+10 more
Iambic Therapeutics, Inc 243
Not applicableNot Yet RecruitingNCT06716775
What this trial is testing

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

Who this might be right for
NSCLC Brain Metastasis
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 200
Testing effectiveness (Phase 2)Study completedNCT00080938
What this trial is testing

Temozolomide and Radiation Therapy in Treating Patients With Brain Metastasis Secondary to Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Eastern Cooperative Oncology Group 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT02696993
What this trial is testing

Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Metastatic Malignant Neoplasm in the BrainStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Study completedNCT04946019
What this trial is testing

MR-Linac Guided Adaptive FSRT for Brain Metastases From Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 55
Testing effectiveness (Phase 2)Study completedNCT01657799
What this trial is testing

Comparison of Veliparib and Whole Brain Radiation Therapy (WBRT) Versus Placebo and WBRT in Adults With Brain Metastases From Non-Small Cell Lung Cancer

Who this might be right for
Brain Metastases From Non-small Cell Lung Cancer
AbbVie (prior sponsor, Abbott) 307
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06974370
What this trial is testing

Avoiding Radiation Therapy Due to Intracranial Response to Chemotherapy, Targeted Therapy and/or Immuno-ONcology Therapy for Brain Metastases: Pilot Pragmatic Trial

Who this might be right for
Brain Metastases, AdultBrain Metastases From Non-small Cell Lung Cancer (NSCLC)
University of Vermont Medical Center 45
Testing effectiveness (Phase 2)Ended earlyNCT04964960
What this trial is testing

Pembro+Chemo in Brain Mets

Who this might be right for
Lung CancerLung Cancer MetastaticBrain Cancer+1 more
John L. Villano, MD, PhD 3
Load More Results